Healing peptide protocols — BPC-157, TB-500, GHK-Cu. Reconstitution math, dose ranges, stacking, cycle length, and what the literature actually shows.
Recovery peptides are studied for soft-tissue and connective-tissue repair. BPC-157 and TB-500 are the two most referenced and are frequently run together, since they are described in the literature as acting through complementary pathways — angiogenesis and cell migration respectively — over 4–8 week cycles.
Protocols covered: BPC-157, TB-500, BPC-157 / TB-500 Blend, GHK-Cu, LL-37, Pentadecapeptide.
BPC-157: 250 – 500 mcg, Daily to 2× daily. Cycle: 4–8 weeks acute; 2 weeks/month maintenance. TB-500: 2 – 10 mg, 1–2×/week. Cycle: 4-week loading + 4–8 week maintenance. BPC-157 / TB-500 Blend: 0.25 – 0.5 mg of each peptide per dose (0.05 – 0.10 ml from a 2 ml reconstitution), BPC-157 component daily or 2× daily; TB-500 loading 2×/week, then 1×/week maintenance — most users inject the blend daily during the 4-week loading phase, then taper TB-500 by reducing frequency. Cycle: 4-week loading (daily) + 4–8 week maintenance (2–3×/week), then 2–4 week break. GHK-Cu: 0.5 – 3 mg, Daily or split doses. Cycle: 8 weeks on, 4 weeks off (injectable). LL-37: 50 – 400 mcg, Daily or every other day. Cycle: 4–8 weeks for acute issues; not for long-term continuous use. Pentadecapeptide: 250 – 750 mcg, Daily or 2× daily. Cycle: 4–8 weeks on, 2–4 weeks off.